A
Title: Accuracy Assessment of Chinese Large Language Models in Psoriasis Management: A Multicenter Expert Consensus Study
Jianjun Huang
Chaofeng Chen1,3, Hao Huang2, Bo Yu3, Xiaoping Hu3, Jialiang Shi4, Fangpei Wu5, Keren Zhou3, Yufang Yao6, Xingyun Zhao7, Jieyi Wang3,8, Zhuoxuan Chen3,8, Jingwen Wu3,8, Jianjun Huang2, Xiaoli Li1
Email: huangjin@szu.edu.cn
1Department of Dermatology, the Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China.
2College of Electronics and Information Engineering, Shenzhen University, Shenzhen, China.
3Department of Dermatology, Peking University Shenzhen Hospital, Shenzhen, China.
4Department of Dermatology, Shenzhen University General Hospital, Shenzhen, China.
5Department of Dermatology, Changsha Central Hospital, Changsha, China.
6Department of Dermatology, Aerospace Central Hospital, Beijing, China.
7Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang, China.
8Department of Dermatology, Shenzhen Xinhua Hospital, Shenzhen, China.
Corresponding author:
Xiaoli Li
Email: anjala@163.com
Abstract
Background
Psoriasis patients in China face significant challenges due to insufficient disease knowledge and limited access to medical resources, creating a need for reliable educational tools.
Objectives
This multicenter consensus study aimed to systematically evaluate the consultation quality of mainstream Chinese large language models (LLMs) for psoriasis patient education.
Methods
"365 Questions on Psoriasis" was jointly compiled by 109 Chinese psoriasis experts. Using an expert assessment methodology, nine dermatologists curated 40 high-frequency clinical questions from the book across five domains (etiology, triggers, treatment, management, psychosocial impact). Four Chinese LLMs (DeepSeek-R1, DeepSeek-V3, GLM-4, Qwen-3) were evaluated through double-blind scoring on a 10-point Likert scale assessing accuracy, completeness, clarity, and safety.
Results
Performance varied significantly, with mean scores ranging from 5.95 to 9.88 (SD: 0-3.05). Qwen-3 achieved the highest average score (9.12), while GLM-4 showed the greatest inconsistency. All responses avoided dangerous content, and 87.5% proactively emphasized the necessity of consulting a physician. However, 12.5% of responses deviated from evidence-based guidelines, particularly on complex topics like biologics and management.
Conclusions
Chinese LLMs show substantial potential for psoriasis education by providing generally safe information and appropriately directing users to doctors. However, current limitations exist, including performance inconsistency and occasional deviations from guidelines on specialized topics, indicating they are not yet replacements for professional medical.
Keywords:
psoriasis
artificial intelligence
large language models
patient education
medical dermatology
Main text:
Background
Psoriasis is a common chronic inflammatory skin disease affecting millions worldwide, characterized by erythema, scaling, and itching. Despite advancements in treatments—including topical medications, phototherapy, and biologics—patients still face reduced quality of life and low treatment satisfaction. Studies show that over 50% of moderate-to-severe psoriasis patients report poor disease control [1], impacting both physical health and psychosocial functioning. Effective psoriasis management requires collaborative doctor-patient efforts, involving complex knowledge about etiology, recurrence mechanisms, treatment options, and lifestyle adjustments [2].
Patient education is crucial in psoriasis management. Adequate understanding of the disease, triggers, and treatment options can significantly improve adherence and self-management, enhancing quality of life. However, traditional education methods, such as in-person consultations or printed materials, are time-consuming and burdensome for clinicians [3]. With the rise of digital health, patients increasingly seek medical information online, further straining healthcare providers [4].
Recent advances in artificial intelligence (AI) offer new possibilities for medical communication [5]. Large language models, as advanced natural language processing tools, can generate human-like responses and are widely used in education, customer service, and medical consultations [6]. In healthcare, LLMs hold promise for delivering quick, accessible information, particularly in non-English contexts like Chinese. However, their application requires rigorous evaluation to ensure accuracy, reliability, and safety [7].
This study evaluates four mainstream Chinese closed-source LLMs in addressing common psoriasis patient queries. By systematically analyzing response quality, we aim to guide clinicians and patients in using AI tools and inform future research and development.
Methods
Study Design
This multicenter expert consensus study assessed the performance of four Chinese LLMs in responding to psoriasis-related questions. The study comprised three phases: question collection, model testing, and expert evaluation.
Model Selection
Four mainstream Chinese closed-source LLMs were selected: DeepSeek-R1 [8], DeepSeek-V3 [9], Qwen-3 [10], and GLM-4 [11]. These models were chosen for their strong performance in Chinese natural language processing tasks and widespread use.
Question Collection
Nine dermatologists from multiple hospitals contributed 40 high-frequency psoriasis-related questions. Each expert provided up to 10 questions, ensuring coverage of five key domains:
1.
Disease etiology and pathophysiology
2.
Triggers and recurrence mechanisms
3.
Treatment options, including biologics
4.
Disease management and lifestyle adjustments
5.
Psychosocial impact and quality of life
All questions were formulated in Chinese, reflecting real-world patient inquiries, and were reviewed for relevance and representativeness.
Data Collection
The 40 questions were input into the four LLMs, and responses were recorded for evaluation.
Evaluation Method
Nine dermatologists independently assessed response quality using a 10-point Likert scale (1 = lowest, 10 = highest). Criteria included:
Accuracy: Alignment with evidence-based medicine
Completeness: Coverage of necessary information
Clarity: Ease of understanding
Safety: Absence of dangerous or misleading content
Experts also noted deviations from evidence-based guidelines and whether responses included recommendations to consult a physician.
Data Analysis
Scores from the nine experts were aggregated to calculate mean scores and standard deviations for each model. Representative responses and score distributions are presented in Table 1 and Figs. 14.
Table 1
A question 'What are the side effects of long-term topical steroid use in psoriasis patients?' answered by Deepseek-R1, Deepseek-V3, Qwen-3, and Glm-4.
Model
Answer
Mean score
Standard deviation
Deepseek-R1
Although long-term use of topical corticosteroids (such as hydrocortisone, halobetasol, etc.) by psoriasis patients can effectively relieve inflammation and itching, it may cause the following side effects and should be used cautiously under the guidance of a doctor: ……
8.7
0.58
Deepseek-V3
Long-term use of topical corticosteroids (hereinafter referred to as "steroids") by psoriasis patients may lead to various side effects, particularly evident with improper use (such as overdose, excessive area, long-term continuous use). The following are the main categories of side effects: ……
8.81
0.44
Qwen-3
Although long-term topical use of corticosteroids (commonly known as "steroids") in psoriasis patients has good short-term efficacy in controlling the condition, reducing inflammation, and scaling, improper or prolonged use may lead to a series of side effects. The following are common topical corticosteroid side effects: ……
9.12
0.59
Glm-4
Psoriasis is a chronic skin disease often characterized by red patches and scales on the skin. Corticosteroids (such as glucocorticoids) are common topical medications for treating psoriasis, but long-term use may bring some side effects. Here are some common side effects: ……
7.53
1.08
Fig. 1
Evaluation scores of Deepseek-R1's responses given by each dermatologist.
Click here to Correct
Fig. 2
Evaluation scores of Deepseek-V3's responses given by each dermatologist.
Click here to Correct
Fig. 3
Evaluation scores of Qwen-3's responses given by each dermatologist.
Click here to Correct
Fig. 4
Evaluation scores of Glm-4's responses given by each dermatologist.
Click here to Correct
Results
Overall Scores
The four LLMs achieved mean scores ranging from 5.95 to 9.88 (SD: 0–3.05), indicating high expert satisfaction. Table 1 displays responses to a representative question: "What are the side effects of long-term topical steroid use in psoriasis patients?"
Score Distribution
Figures 14 illustrate score distributions for each model. DeepSeek-R1 and DeepSeek-V3 scores clustered between 7–9, while Qwen-3 showed more consistent high ratings. GLM-4 exhibited greater variability, reflecting uneven performance.
Response Characteristics
All models avoided dangerous or misleading information, a key positive finding. Most responses included disclaimers like "consult a physician," enhancing safety. However, some answers scored lower due to incomplete or non-evidence-based content, particularly for complex topics like biologics.
Discussion
This multicenter expert consensus study represents the first comprehensive evaluation of Chinese large language models in the context of psoriasis patient education. The findings reveal a dual narrative of notable promise alongside critical limitations, offering valuable insights for both clinical practice and AI development. The observed performance variation across models—with mean scores ranging from 5.95 to 9.88—clearly demonstrates that not all commercially available LLMs are equally suited for specialized medical consultation. Among the evaluated models, Qwen-3 emerged as the top performer, achieving a mean score of 9.12. This success underscores the technical feasibility of developing LLMs capable of delivering high-quality, patient-centered responses. In contrast, GLM-4 exhibited significant inconsistency in its responses, with a standard deviation of up to 3.05, highlighting the ongoing challenges in ensuring clinical reliability across diverse medical queries.
A key strength identified in this study was the universal adherence of all models to fundamental safety protocols. Notably, every evaluated LLM successfully avoided generating dangerous or misleading content, and an overwhelming majority (87.5%) proactively emphasized the necessity of consulting a physician. This represents a substantial improvement over traditional online health information sources, which often lack rigorous oversight and may propagate misinformation. Furthermore, the models excelled in providing clear, structured explanations for foundational topics such as the side effects of topical steroids. By distilling complex medical concepts into patient-friendly language, these LLMs demonstrated their potential to serve as valuable educational tools. Such capabilities could significantly reduce the burden on clinicians by addressing routine patient inquiries, allowing healthcare providers to allocate more time to complex cases and personalized care.
Despite these strengths, the study also uncovered persistent gaps in the models' performance, particularly in specialized areas of psoriasis management. Approximately 12.5% of responses deviated from evidence-based guidelines, with notable inaccuracies arising in discussions of biologics' mechanisms of action, combination therapy sequencing, and complex management scenarios. These inconsistencies likely stem from inadequate domain-specific training data and insufficient clinical validation processes. While the models performed well in identifying common psoriasis triggers—such as stress and infections—their management advice often lacked depth and personalization. The tendency to provide generalized responses represents a critical limitation, as it fails to account for the heterogeneous nature of psoriasis, which manifests in diverse phenotypes and requires tailored treatment approaches.
A
These findings resonate with broader observations in the literature regarding the limitations of LLMs in medical applications. Prior studies have noted that current models often struggle with context-dependent reasoning, a capability essential for managing chronic conditions like psoriasis, where individualized care is paramount. Our study extends these observations to the Chinese-language dermatology context, where linguistic nuances and regional treatment preferences introduce additional layers of complexity. For instance, while the models occasionally referenced traditional Chinese medicine, these mentions were not systematically integrated into evidence-based recommendations, reflecting a gap in culturally relevant training data.
In summary, this study highlights both the potential and the current limitations of Chinese LLMs in psoriasis patient education. While they excel in safety and foundational knowledge dissemination, their performance in specialized and personalized care remains inconsistent. Addressing these gaps will require enhanced collaboration between AI developers and clinical experts, as well as the incorporation of more robust, domain-specific training datasets. Until these improvements are realized, LLMs should be viewed as supplementary tools—valuable for basic education but insufficient for guiding complex treatment decisions without clinician oversight.
Conclusions
Chinese LLMs demonstrate substantial potential as supplementary tools for psoriasis patient education, particularly in improving health literacy regarding disease fundamentals, medication safety, and basic self-management. Qwen-3 currently delivers the most clinically reliable performance among evaluated models. However, significant limitations persist in handling specialized therapeutic areas (notably biologics and complex management scenarios) and providing individualized recommendations.
Key implications for practice:
1.
​Selective Implementation​​: Healthcare systems should prioritize rigorously validated models like Qwen-3 for delivering standardized educational content about topical therapies and lifestyle management.
2.
​Mandatory Human Oversight​​: All LLM-generated advice regarding systemic treatments, biologics, or treatment modifications must undergo clinician verification before dissemination to patients.
3.
​Clear Scope Definition​​: Patient-facing interfaces should explicitly state model limitations, particularly regarding treatment individualization and complex case management.
4.
​Continuous Validation Framework​​: Developers must establish ongoing clinical evaluation mechanisms, especially for rapidly evolving therapeutic domains like biologics.
Future development should focus on enhancing evidence-based reasoning through curated dermatology datasets, implementing specialist review protocols, and developing hybrid human-AI education systems. Until these advancements are realized, LLMs should be positioned strictly as informational supplements for clinician-guided psoriasis education.
Declarations
Ethics approval and consent to participate:
Not applicable.
Consent for publication:
Not applicable.
A
Data Availability
All data supporting the findings of this study are available within the paper and its Supplementary Information.
Competing interests:
The authors have no conflict of interest to declare.
A
Funding:
This work was supported by Natural Science Foundation of Guangdong Province (No.2025A1515010947) and Shenzhen Sanming Project (No. SZSM202311029).
A
Author Contribution
BY, XH, JS, FW, KZ, YY, XZ, JW, ZC collected questions and LLM scores. JW collected data. CC, HH conducted data statistics and analysis, and CC was a major contributor in writing the manuscript. JH, XL designed and guided the experiments, and provided supervision. All authors read and approved the final manuscript.
Acknowledgements:
The study was supported by Shenzhen Research Grants(200901013). We thank Shenzhen Public Service Platform of Biomedical Technology for the technical support.
Electronic Supplementary Material
Below is the link to the electronic supplementary material
References
1.
Raharja, A., Mahil, S. K. & Barker, J. N. Psoriasis: a brief overview[J]. Clin. Med. 21 (3), 170–173 (2021).
2.
Li, T. et al. Potential effects and mechanisms of Chinese herbal medicine in the treatment of psoriasis[J]. J. Ethnopharmacol. 294, 115275 (2022).
3.
Dressler, C. et al. Therapeutic patient education and self-management support for patients with psoriasis–a systematic review[J]. JDDG: J. der Deutschen Dermatologischen Gesellschaft. 17 (7), 685–695 (2019).
4.
Jiang, Y. et al. Patients’ and healthcare providers’ perceptions and experiences of telehealth use and online health information use in chronic disease management for older patients with chronic obstructive pulmonary disease: a qualitative study[J]. BMC Geriatr. 22 (1), 9 (2022).
5.
Alowais, S. A. et al. Revolutionizing healthcare: the role of artificial intelligence in clinical practice[J]. BMC Med. Educ. 23 (1), 689 (2023).
6.
Lucas, H. C., Upperman, J. S. & Robinson, J. R. A systematic review of large language models and their implications in medical education[J]. Med. Educ. 58 (11), 1276–1285 (2024).
7.
Yang, R. et al. Large language models in health care: Development, applications, and challenges[J]. Health Care Sci. 2 (4), 255–263 (2023).
8.
Guo, D. et al. Deepseek-r1: Incentivizing reasoning capability in llms via reinforcement learning[J]. (2025). arXiv preprint arXiv:2501.12948.
9.
Liu, A. et al. Deepseek-v3 technical report[J]. arXiv preprint arXiv:2412.19437, (2024).
10.
Yang, A. et al. Qwen3 technical report[J]. arXiv preprint arXiv:2505.09388, (2025).
11.
GLM, T. et al. Chatglm: A family of large language models from glm-130b to glm-4 all tools[J]. (2024). arXiv preprint arXiv:2406.12793.
Legend.
Click here to Correct
Click here to Correct
Click here to Correct
Click here to Correct
Table 1 A question 'What are the side effects of long-term topical steroid use in psoriasis patients?' answered by Deepseek-R1, Deepseek-V3, Qwen-3, and Glm-4.
Model
Answer
Mean score
Standard deviation
Deepseek-R1
Although long-term use of topical corticosteroids (such as hydrocortisone, halobetasol, etc.) by psoriasis patients can effectively relieve inflammation and itching, it may cause the following side effects and should be used cautiously under the guidance of a doctor:
Click here to download actual image
I. Local Skin Side Effects
1. Skin Atrophy
o Long-term use can lead to thinning of the epidermis, reduction of dermal collagen, making the skin fragile and prone to cracks or bruising.
2. Telangiectasia (Capillary Dilation)
o Corticosteroids inhibit blood vessel contraction, leading to the appearance of red blood vessels on the skin surface, commonly seen in thin and delicate areas like the face and groin.
3. Folliculitis/Acneiform Eruptions
o Corticosteroids may induce follicular orifice blockage or bacterial infection, manifesting as red papules or pustules.
4. Pigmentation Abnormalities
o Hypopigmentation (skin lightening) or hyperpigmentation (skin darkening), especially more noticeable in individuals with darker skin tones.
5. Hypertrichosis
o Localized hair may abnormally increase in growth and thickness.
Click here to download actual image
II. Issues Related to Discontinuation
1. Rebound Phenomenon (Worsening of Condition)
o Sudden discontinuation may lead to recurrence or worsening of original lesions, or even the emergence of more severe pustular psoriasis.
2. Steroid-Dependent Dermatitis
o The skin becomes dependent on corticosteroids; withdrawal reactions such as redness, swelling, burning, and desquamation occur after stopping use.
Click here to download actual image
III. Systemic Side Effects (Uncommon but Serious)
Cushing's Syndrome (with long-term, large-area use of potent corticosteroids):
o Manifestations include moon face, buffalo hump, hypertension, elevated blood sugar, etc.
Hypothalamic-Pituitary-Adrenal (HPA) Axis Suppression:
o Affects the body's hormone secretion, leading to fatigue, hypotension, etc.
Click here to download actual image
IV. Other Risks
Secondary Infections: Corticosteroids suppress local immunity, potentially worsening fungal (e.g., Candida) or bacterial (e.g., Staphylococcus aureus) infections.
Masking Infection Symptoms: Corticosteroids may reduce redness and swelling, masking the early signs of underlying infections.
Click here to download actual image
How to Reduce Side Effects?
1. Strictly Follow Doctor's Orders: Use according to the prescribed course and dosage; avoid self-extending the medication period.
2. Choose Appropriate Potency: Use low-potency corticosteroids (e.g., hydrocortisone) on the face and intertriginous areas; medium to high potency may be used on the trunk or thick lesions, but avoid long-term use.
3. Combination Therapy: Alternate use with non-corticosteroid medications (e.g., vitamin D3 analogs like calcipotriol, calcineurin inhibitors).
4. Regular follow-ups: Doctor assesses efficacy and side effects and adjusts the treatment plan.
5. Gradual Discontinuation: Avoid abrupt cessation; consider "intermittent therapy" or gradually reducing application frequency.
Click here to download actual image
Alternative Treatment Suggestions
Phototherapy (Narrowband UVB): Suitable for moderate to severe patients, with relatively high safety.
Biologics: Target moderate to severe or refractory cases, providing targeted immune modulation.
Moisturization and Repair: Use moisturizers containing ceramides, urea, etc., to repair the skin barrier.
Psoriasis requires individualized treatment. Long-term medication must be conducted under the guidance of a dermatologist to balance efficacy and safety.
8.7
0.58
Deepseek-V3
Long-term use of topical corticosteroids (hereinafter referred to as "steroids") by psoriasis patients may lead to various side effects, particularly evident with improper use (such as overdose, excessive area, long-term continuous use). The following are the main categories of side effects:
Click here to download actual image
I. Local Side Effects (Common at the application site)
1. Skin Atrophy
o Thinning of the epidermis, reduction of dermal collagen fibers, skin wrinkling, transparency, and susceptibility to damage.
o Severe cases may develop "striae atrophicae" (line-like atrophy).
2. Telangiectasia
o Visible red blood vessels on the skin surface, especially on the face and intertriginous areas (e.g., armpits, groin).
3. Folliculitis/Increased Risk of Infection
o Steroids may suppress local immunity, leading to bacterial (e.g., Staphylococcus aureus), fungal (e.g., Malassezia) infections, or acne-like rashes.
4. Steroid-Dependent Dermatitis
o Rebound erythema, burning, itching, or even worsening of lesions ("rebound phenomenon") may occur after sudden discontinuation, forcing patients to continue medication.
5. Pigmentation Changes
o Hypopigmentation (white spots) or hyperpigmentation (dark spots).
6. Hypertrichosis
o Increased hair growth at the application site.
Click here to download actual image
II. Systemic Side Effects (More common with long-term, large-area use of high-potency steroids)
1. Hypothalamic-Pituitary-Adrenal (HPA) Axis Suppression
o Percutaneous absorption of steroids can inhibit the body's own adrenal corticosteroid secretion, leading to fatigue, hypotension, hypoglycemia, etc. (children are more sensitive).
2. Cushing's Syndrome-like Manifestations
o Centripetal obesity, moon face, buffalo hump, elevated blood sugar, etc. (rare, requires very high doses).
3. Other Metabolic Effects
o Elevated blood sugar, osteoporosis (monitoring required with long-term high-risk use).
Click here to download actual image
III. High-Risk Side Effects in Specific Areas
Face/Periorbital Area: Prone to steroid-dependent dermatitis, glaucoma (if steroids penetrate into the eye).
Skin Folds (e.g., groin, armpits): Thin skin, high absorption rate, more prone to atrophy and infection.
Genital Mucosa: May exacerbate irritation or lead to excessive absorption.
Click here to download actual image
IV. Psoriasis-Specific Risks
1. Rebound Exacerbation
o Sudden discontinuation may lead to flare-ups or transformation into more severe types (e.g., pustular psoriasis).
2. Risk of Erythroderma
o Abuse of potent steroids may induce systemic erythroderma (rare but serious).
3. Reduced Tolerance (Tachyphylaxis)
o Efficacy decreases after long-term use, requiring higher potency steroids or switching to other medications.
Click here to download actual image
How to Reduce Side Effects?
1. Strictly Follow Doctor's Orders
o Choose appropriate steroid potency (e.g., low potency for face, medium/high potency for trunk/limbs).
o Avoid continuous use for more than 2–4 weeks (adjusted based on location and steroid potency).
2. Intermittent Therapy or Rotating Medications
o Such as "weekend therapy" (use steroids on weekends, non-steroidal drugs like vitamin D3 analogs or calcineurin inhibitors on weekdays).
3. Combination Therapy
o Combine with non-steroidal medications (e.g., tacrolimus, calcipotriol) to reduce steroid dosage.
4. Regular Monitoring
o Check adrenal function, blood sugar, etc., during long-term, large-area use.
Click here to download actual image
Summary
Short-term rational use of steroids is an important part of psoriasis treatment, but long-term abuse carries significant risks. Patients should use medication standardizedly under doctor's guidance and regularly assess skin and systemic conditions, adjusting the treatment plan (e.g., switching to biologics or systemic drugs) if necessary.
8.81
0.44
Qwen-3
Although long-term topical use of corticosteroids (commonly known as "steroids") in psoriasis patients has good short-term efficacy in controlling the condition, reducing inflammation, and scaling, improper or prolonged use may lead to a series of side effects. The following are common topical corticosteroid side effects:
Click here to download actual image
I. Local Side Effects
1. Skin Atrophy
o Long-term use of potent corticosteroids can cause thinning of the skin, loss of elasticity, and even telangiectasia.
o Commonly occurs in areas with thinner skin such as the face, armpits, and groin.
2. Telangiectasia
o Corticosteroids cause dilation of blood vessels in the dermis, manifesting as visible redness or spider veins on the skin surface.
3. Hyperpigmentation or Hypopigmentation
o May result in darkening (hyperpigmentation) or lightening (hypopigmentation) of the skin, particularly more noticeable in individuals with darker skin tones.
4. Acneiform Eruption / Folliculitis
o Corticosteroids can stimulate sebaceous gland secretion, leading to acne-like rashes or secondary bacterial infections.
5. Hypertrichosis
o Localized increase in hair growth, commonly seen in children and women.
6. Rebound Phenomenon
o Rapid recurrence of psoriasis after discontinuation, sometimes more severe than before, especially with the use of potent corticosteroids.
7. Corticosteroid-Induced Dermatitis
o After long-term use, the skin becomes dependent on corticosteroids; discontinuation leads to symptoms such as itching, erythema, and scaling.
8. Increased Risk of Secondary Infections
o Corticosteroids suppress immune responses, potentially making the skin more susceptible to fungal, bacterial, or viral infections (e.g., herpes simplex, shingles).
Click here to download actual image
II. Systemic Side Effects (Less Common but Require Vigilance)
Although the absorption of topical corticosteroids is relatively low, systemic side effects may still occur with large-area, long-term use, or with ultra-potent corticosteroids, including:
1. Adrenal Cortex Suppression
o Suppression of the body's own hormone secretion, which in severe cases can lead to adrenal insufficiency.
2. Cushing's Syndrome
o Manifestations include moon face, buffalo hump, central obesity, etc.
3. Growth Retardation in Children
o Especially in children with large-area use, it may affect height development.
4. Hyperglycemia, Hypertension
o Metabolic disorders may occur in extreme cases.
Click here to download actual image
III. How to Use Corticosteroids Safely?
1. Select Appropriate Potency
o Choose corticosteroid preparations of different strengths based on the severity of the condition and the affected area:
♣ Potent: Used for plaque psoriasis (e.g., scalp, elbows, knees)
♣ Moderate to Mild: Used for the face, skin folds
2. Control Duration of Use
o Generally recommended for continuous use not exceeding 2–4 weeks, especially for potent corticosteroids.
3. Intermittent Therapy or Combination Therapy
o Consider combination therapy such as "corticosteroids + vitamin D3 analogs/calcineurin inhibitors" to reduce corticosteroid dosage and side effects.
4. Gradual Tapering for Discontinuation
o Do not stop abruptly; gradually reduce the dose to avoid rebound phenomenon.
5. Regular Follow-Up with a Doctor
o Use medication under professional guidance and monitor for adverse reactions.
Click here to download actual image
IV. Alternative or Adjunctive Treatments
For long-term control of psoriasis, the following non-corticosteroid medications or methods can be considered:
Vitamin D3 Analogs (e.g., Calcipotriene)
Calcineurin Inhibitors (e.g., Tacrolimus, Pimecrolimus)
Biologics (suitable for moderate to severe patients)
Phototherapy (Narrowband UVB)
Traditional Chinese Medicine (under guidance from a qualified hospital)
Click here to download actual image
Summary
Although topical corticosteroids work quickly, long-term use alone is not recommended, especially in sensitive areas or pediatric patients. They should be used reasonably under the guidance of a dermatologist, and combined with other treatment methods when necessary to reduce the risk of side effects and achieve better long-term control.
If you have specific drug names or usage situations, you can tell me, and I can help you further analyze.
9.12
0.59
Glm-4
Psoriasis is a chronic skin disease often characterized by red patches and scales on the skin. Corticosteroids (such as glucocorticoids) are common topical medications for treating psoriasis, but long-term use may bring some side effects. Here are some common side effects:
1. Skin Atrophy: Long-term use of corticosteroids may lead to thinning and atrophy of the skin, reducing skin elasticity.
2. Hyperpigmentation or Depigmentation: Corticosteroids may cause uneven skin pigmentation, resulting in spots or loss of pigment.
3. Telangiectasia: Long-term use may cause dilation of superficial capillaries, appearing as redness or spider veins.
4. Corticosteroid-Induced Dermatitis: After discontinuation, skin inflammation may worsen, leading to dependence on corticosteroids.
5. Increased Risk of Infection: Corticosteroids may suppress local immune responses in the skin, increasing the risk of infection.
6. Skin Dryness and Itching: Long-term use may cause discomfort such as dry skin and itching.
7. Acneiform Eruption: Corticosteroids may lead to the appearance of acne-like rashes.
8. Systemic Side Effects: Although systemic absorption of topical corticosteroids is limited, long-term and large-area use may still cause systemic side effects, such as adrenal suppression, elevated blood sugar, and osteoporosis.
9. Rebound Phenomenon: The condition may suddenly worsen after discontinuation, known as the "rebound phenomenon."
To reduce these side effects, it is recommended to use corticosteroids reasonably under a doctor's guidance, avoid long-term and large-area use, and gradually reduce the dose or switch to other treatments based on the condition. Regular follow-ups to monitor skin condition and other physical indicators are also very important.
7.53
1.08
Total words in MS: 3644
Total words in Title: 16
Total words in Abstract: 211
Total Keyword count: 5
Total Images in MS: 8
Total Tables in MS: 2
Total Reference count: 12